You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 72 No. 4, October 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Comparison Between Pilocarpine and Echothiophate for Chronic Simple Glaucoma

A Comparison Between 4% Pilocarpine and 0.06% Echothiophate Iodide in the Diurnal Management of Chronic Simple Glaucoma

JOHN A. PRATT-JOHNSON, MB, FRCS; STEPHEN M. DRANCE, MD, FRCS; ROY INNES

Arch Ophthalmol. 1964;72(4):485-488.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The use of 0.25 and 0.125% echothiophate iodide (Phospholine Iodide) in the management of open-angle glaucoma has been widely accepted. Its use has been confined to those patients in whom the more conventional medical therapy has failed. Initial local side effects, sometimes quite severe, have been an unpleasant feature with this drug, but in many patients these settle after a week or two. Echothiophate iodide 0.06% has recently been introduced in an endeavor to cut down on the unpleasant side effects. Reports of the efficacy of this medication have appeared,1-3 and the suggestion was made that even this low concentration of echothiophate iodide is more effective in maintaining the intraocular pressures on a diurnal basis (round the clock) than the more frequent instillation of pilocarpine.1

The present study was concerned with a comparison of the diurnal pressure control and side effects in open-angle glaucoma between 4% pilocarpine administered . . . [Full Text PDF of this Article]


Author Affiliations

Vancouver, BC, Canada

From the Glaucoma Service, University of British Columbia, and the Department of Ophthalmology, Shaughnessy Hospital, Department of Veteran Affairs.


Footnotes

Submitted for publication May 10, 1964.

This study was partially supported by DVA research grant No. 10-63 and Federal Provincial Health research grant No. 609-7-58.

The echothiophate iodide was kindly supplied by Campbell Pharmaceuticals Inc.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.